Who is sponsoring NCT03612284?

NCT03612284 is sponsored by Jennifer Fogt.

What drugs are being tested in NCT03612284?

Interventions in NCT03612284: contact lens insertion solution.

What condition does NCT03612284 study?

NCT03612284 studies Irregular; Contour of Cornea.

Is NCT03612284 still recruiting?

NCT03612284 is currently completed. Last updated 18 January 2019.

Last reviewed 2019-01-18 · How we verify

NCT03612284

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Scleral Contact Lens Insertion Solution Study

Completed NA Last updated 18 January 2019

What this trial tests

NA trial testing contact lens insertion solution in Irregular; Contour of Cornea in 30 participants. Completed in 30 November 2018.

Timeline

27 November 2017

Primary endpoint
30 November 2018

30 November 2018

Quick facts

Lead sponsor	Jennifer Fogt
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	30
Start date	27 November 2017
Primary completion	30 November 2018
Estimated completion	30 November 2018
Sites	1 location across United States

Drugs / interventions tested

contact lens insertion solution

Conditions studied

Irregular; Contour of Cornea — all drugs for Irregular; Contour of Cornea →

Sponsor

Jennifer Fogt

Who can join

18 and older, any sex, with Irregular; Contour of Cornea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the clinical ocular compatibility (feasibility of safety and efficacy) of a patented solution (US Patent 2,259,437, Stone) which contains multiple essential ions and has a pH and tonicity which more closely mimics human tears as compared to the subjects' current habitual scleral lens insertion solution.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Jennifer Fogt trials

Trials by the same sponsor.

NCT06053463 — Evaluation of Soft Multifocal Lenses in Presbyopic Previous Contact Lens Wearers · NA · completed
NCT02643095 — Efficacy of Scleral Contact Lenses for Daily Wear for Regular and Irregular Refractive Errors Compared to Habitually Wor · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03612284 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jennifer Fogt
Last refreshed: 18 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03612284.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing